ZHANG Xiaoju. Effect of Yishen Huoxue Decoction for patients with chronic renal failure differentiated as syndrome of qi deficiency of spleen and kidney[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 27-30. DOI: 10.7619/jcmp.202014007
Citation: ZHANG Xiaoju. Effect of Yishen Huoxue Decoction for patients with chronic renal failure differentiated as syndrome of qi deficiency of spleen and kidney[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 27-30. DOI: 10.7619/jcmp.202014007

Effect of Yishen Huoxue Decoction for patients with chronic renal failure differentiated as syndrome of qi deficiency of spleen and kidney

More Information
  • Received Date: April 20, 2020
  • Objective To explore the effect of Yishen Huoxue Decoction on levels of serum transforming growth factor-β1(TGF-β1)and bone morphogenetic protein-7(BMP-7)in patients with chronic renal failure(CRF)differentiated as syndrome of qi deficiency of spleen and kidney. Methods Totally 120 patients with CRF differentiated as syndrome of qi deficiency of spleen and kidney were randomly divided into study group and control group, with 60 cases in each group. The control group was treated with captopril tablets and Shenshuaining Capsules, and the study group was treated with Yishen Huoxue Decoction. The levels of serum TGF-β1 and BMP-7, score of traditional Chinese medicine(TCM)syndrome and clinical efficacy were compared between the two groups before and after treatment. Results After treatment, the serum TGF-β1 level in the study group was significantly lower than that in the control group(P<0.05), while the serum BMP-7 level was significantly higher than that in the control group(P<0.05). After treatment, the score of TCM syndrome in the study group was significantly lower than that in the control group(P<0.05). The total effective rate of the study group was 80.00%, which was significantly higher than 56.67% of the control group(P<0.05). During the course of treatment, no patient had adverse reactions such as fever and allergy. Conclusion Yishen Huoxue Decoction is safe and effective in the treatment of patients with CRF differentiated as syndrome of qi deficiency of spleen and kidney, which can reduce the level of serum TGF-β1, increase the level of serum BMP-7, and improve the prognosis of patients.
  • 杨帆, 贾泽会. 慢性肾衰病机演变及证治探讨[J]. 中国中医基础医学杂志, 2017, 23(7): 907-908

    , 917.
    李思. 老年终末期肾病伴肿瘤患者血液透析中医证型分布及骨代谢相关指标变化研究[J]. 中华肿瘤防治杂志, 2018, 25(S2): 83-84.
    齐振强, 任鲁颖, 冯国庆, 等. 慢性肾功能衰竭中医临床研究进展[J]. 中华中医药学刊, 2016, 34(8): 2006-2009.
    莫超, 史伟, 谢丽萍, 等. 原发性肾小球疾病中医证型与生化指标的相关性[J]. 中国老年学杂志, 2018, 38(23): 5758-5760.
    王河宝, 孙悦, 曹征, 等. 慢性肾功能衰竭中医发病机理探讨[J]. 时珍国医国药, 2019, 30(1): 155-156.
    于大君, 周群清, 徐曼, 等. 老年慢性肾脏病的中医认识刍议[J]. 中华中医药杂志, 2017, 32(12): 5493-5495.
    雷蕾, 熊维建, 钟锦, 等. 《慢性肾衰竭中医诊疗指南》临床应用评价体会[J]. 中华中医药杂志, 2016, 31(9): 3617-3619.
    国家食品药品监督管理局. 中药新药临床研究指导原则(试行)[S]. 北京: 中国医药科技出版社, 2000: 359-360.
    陈司汉, 柳尧, 曾炎, 等. 肾康宁胶囊对显性糖尿病肾病脾肾气虚证病情进展的延缓作用[J]. 中国实验方剂学杂志, 2017, 23(10): 183-188.
    张艳琴, 辛晓龙, 李文东, 等. 高通量血液透析对慢性肾衰患者钙磷代谢紊乱的疗效分析[J]. 实用临床医药杂志, 2016, 20(11): 179-180

    , 184.
    HEE LEE M I, CHOI E N, JEON Y J, et al. Possible role of transforming growth factor-β1and vascularendothelial growth factor in Fabry disease nephropathy[J]. International Journal of Molecular Medicine, 2012, 30(6): 1275-1280.
    蒲晓东, 杨艳梅. 基于慢性肾衰的中医临床研究论肾主泄浊[J]. 中国中医基础医学杂志, 2018, 24(8): 1054-1055

    , 1058.
    杨波, 乔延恒, 赵岩茹, 等. 从十年文献分析探寻中医药诊治慢性肾衰竭病因病机[J]. 辽宁中医杂志, 2016, 43(1): 58-59.
    胡天祥, 李茵, 黎创, 等. 从三焦论治慢性肾衰的理论探讨[J]. 中国中医基础医学杂志, 2019, 25(7): 898-900.
    水光兴, 孙伟. 论中医肾脏病学的发展[J]. 中华中医药杂志, 2016, 31(3): 755-757.
    韩海燕, 路建饶, 王新华. 肾衰方对CKD4期慢性肾衰患者肾功能及钙磷代谢的影响[J]. 辽宁中医杂志, 2017, 44(2): 312-315.
    李建英, 于俊生. 于俊生运用对药治疗慢性肾衰经验[J]. 中华中医药杂志, 2016, 31(6): 2182-2184.
    张兴坤, 张丽, 张宗礼. 张宗礼醒脾通三焦法治疗慢性肾功能衰竭经验[J]. 中国中医基础医学杂志, 2017, 23(5): 717-719.
  • Related Articles

    [1]LI Tianyi, REN Yue, SONG Zhenya, JIANG Meinan, LI Mengyang, CHEN Yong, YIN Xudong. Research progress of pan-immune inflammation value in prognosis and effect of tumors[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 139-143. DOI: 10.7619/jcmp.20233348
    [2]HU Ru, GUO Huaijuan, WANG Ying, YAN Xuebing, JIANG Qian. Value of C-PLAN index as a prognostic indicator of advanced esophageal cancer patients treated with immune checkpoint inhibitors[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 1-6, 12. DOI: 10.7619/jcmp.20232676
    [3]JI Chao, CHEN Yixiao, LIU Kai, SU Xiaochen, TENG Menghao, GUO Yan, JI Wenchen, LI Meng. Screening of diagnostic biomarkers and their relations with immune cell infiltration in osteoporosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 1-6. DOI: 10.7619/jcmp.20231718
    [4]LI Donglin, GUO Huaijuan, WANG Ying, YAN Xuebing, LU Meiling. Clinical investigation in abundance of Fusobacterium nucleatum in tumor tissues as a prognostic biomarker for stage Ⅱ colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2023, 27(9): 25-31. DOI: 10.7619/jcmp.20230271
    [5]WANG Qiqi, YE Bicheng, WANG Changcheng. Correlation between AHSA1 expression and prognosis of hepatocellular carcinoma based on TCGA database analysis[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 8-17. DOI: 10.7619/jcmp.20213231
    [6]JU Yuejun, SHEN Ting, CHEN Gang, KONG Yinghong. Correlations between LncRNA CRNDE and prognosis, immune infiltration of papillary thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 20-24. DOI: 10.7619/jcmp.20212903
    [7]WEI Xin, LIU Xia, SHI Lin, YUN Fen, JIA Yongfeng. Effect of fucosyltransferase 8 expression on immunecell infiltration and survival prognosis in breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(17): 76-81, 87. DOI: 10.7619/jcmp.20211784
    [8]LIU Dehui, YAN Yulan. Research progress of circRNAs in diagnosis and prognosis of lung cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 124-128. DOI: 10.7619/jcmp.20211851
    [9]ZHANG Zhou, YANG Tingsong, CHEN Xi, WANG Qun, ZHANG Ti, FANG Lin. Correlation between SIRT2 expression in gastric carcinoma tissues and clinical prognosis in gastric cancer patients[J]. Journal of Clinical Medicine in Practice, 2015, (9): 69-72. DOI: 10.7619/jcmp.201509020
    [10]LI Hua, ZHANG Jinsong, ZHANG Qin, LIU Xia, CHEN Yan. Analysis on prognosis factors of acute paraquat intoxication and its emergency treatment[J]. Journal of Clinical Medicine in Practice, 2013, (23): 56-58. DOI: 10.7619/jcmp.201323016
  • Cited by

    Periodical cited type(15)

    1. 吴怀琼,孙文静,林坤,傅杰,马云云. ADOPT干预模式对肝癌腹水患者FACT-G评分及症状困扰程度的影响. 国际护理学杂志. 2024(03): 479-483 .
    2. 夏漫. ADOPT模式的健康教育与情绪引导在消化内镜诊疗中的联合应用价值. 广州医药. 2024(02): 192-197 .
    3. 闫亚文,赵勤芳,汪改改,张凤莲. ADOPT护理模式对高龄足月初产妇母乳喂养率、心理韧性及家庭幸福感的影响. 海南医学. 2024(07): 1031-1036 .
    4. 肖红,张咏梅,徐小艳,秦意,李燕. 问题解决模式在临床护理应用的研究进展. 当代护士(中旬刊). 2024(07): 11-15 .
    5. 吴少梅,刘会茹,陈俊兰. 基于HEART沟通模式的“态度-定义-开放思维-计划-实施”护理方案在数字化导板种植中的应用. 中国当代医药. 2024(21): 176-180 .
    6. 陈红,唐金,韩冬梅. ADOPT模式护理在行放射治疗老年肺癌患者中的应用效果. 中西医结合护理(中英文). 2023(02): 112-114 .
    7. 初淑媛,刘兴华,袁慧婷. ADOPT护理模式对全喉切除术患者自我护理质量及生活质量的改善作用. 中国实用乡村医生杂志. 2023(02): 39-41+45 .
    8. 孙露颖,戴欣,闫澍,王艳. ADOPT模式护理干预对前牙外伤患者即刻种植修复效果的影响. 中国医刊. 2023(10): 1126-1129 .
    9. 叶梅珍,江烟青,王琼. ADOPT护理模式联合团体干预对鼻咽癌患者的影响. 齐鲁护理杂志. 2023(24): 9-12 .
    10. 彭江英,苏俊玲,郭春蕊. ADOPT模式在乳腺癌PICC置管患者中的应用. 中华现代护理杂志. 2022(09): 1233-1237 .
    11. 李佩佩,张玲玲. 基于ADOPT护理策略对脑梗死偏瘫患者神经功能及步态的影响. 现代医药卫生. 2022(17): 3006-3009 .
    12. 张红梅. 循证护理在鼻咽癌患者放疗护理中的效果观察及对并发症发生率的影响. 中国医药指南. 2021(15): 11-13 .
    13. 刘晓新,刘进炼,顾士杨,董桂秋,吴秋月,徐媛. ADOPT问题解决模式在糖尿病肾病早期微量白蛋白尿病人中的应用效果观察. 循证护理. 2021(17): 2342-2345 .
    14. 陈季云,刘琪,汤珍珍. 鼻咽癌患者在放射治疗期间行ADOPT护理模式联合团体干预对其生活质量和张口困难程度的影响. 中西医结合护理(中英文). 2021(03): 110-112 .
    15. 赵姗姗. 晚期胃癌患者接受化学药物治疗期间应用不同护理模式的效果比较. 中西医结合护理(中英文). 2021(12): 157-159 .

    Other cited types(0)

Catalog

    Article views (363) PDF downloads (9) Cited by(15)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return